What is the minimum age requirement for prescribing Qsymia?

The minimum age requirement for prescribing Qsymia, which is a combination medication approved for weight management, is 12 years. This guideline is based on clinical studies that demonstrate its safety and efficacy in treating obesity in adolescents who are 12 years or older. The approval reflects the understanding that obesity is a significant health concern starting in adolescence and that effective pharmacological interventions can be necessary for this population to achieve and maintain a healthy weight.

While younger patients may experience obesity-related health issues, the safety profile of Qsymia has only been established for those aged 12 and older. This ensures that prescribers are adhering to recommended practices that prioritize patient safety and effective treatment outcomes. Consequently, the other options, which suggest younger ages, do not align with the established guidelines for this medication.